These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 19103155)
1. Molecular characterization of the protease from Clostridium botulinum serotype C responsible for nicking in botulinum neurotoxin complex. Suzuki T; Yoneyama T; Miyata K; Mikami A; Chikai T; Inui K; Kouguchi H; Niwa K; Watanabe T; Miyazaki S; Ohyama T Biochem Biophys Res Commun; 2009 Feb; 379(2):309-13. PubMed ID: 19103155 [TBL] [Abstract][Full Text] [Related]
2. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity. Arndt JW; Chai Q; Christian T; Stevens RC Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520 [TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity. Schmidt JJ; Stafford RG Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983 [TBL] [Abstract][Full Text] [Related]
4. BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani. Raffestin S; Dupuy B; Marvaud JC; Popoff MR Mol Microbiol; 2005 Jan; 55(1):235-49. PubMed ID: 15612931 [TBL] [Abstract][Full Text] [Related]
5. Expression and stability of the nontoxic component of the botulinum toxin complex. Miyata K; Yoneyama T; Suzuki T; Kouguchi H; Inui K; Niwa K; Watanabe T; Ohyama T Biochem Biophys Res Commun; 2009 Jun; 384(1):126-30. PubMed ID: 19394306 [TBL] [Abstract][Full Text] [Related]
6. Substrate recognition strategy for botulinum neurotoxin serotype A. Breidenbach MA; Brunger AT Nature; 2004 Dec; 432(7019):925-9. PubMed ID: 15592454 [TBL] [Abstract][Full Text] [Related]
7. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization. Fujinaga Y; Inoue K; Shimazaki S; Tomochika K; Tsuzuki K; Fujii N; Watanabe T; Ohyama T; Takeshi K; Inoue K Biochem Biophys Res Commun; 1994 Dec; 205(2):1291-8. PubMed ID: 7802661 [TBL] [Abstract][Full Text] [Related]
8. A thermostable cysteine protease precursor from a tropical plant contains an unusual C-terminal propeptide: cDNA cloning, sequence comparison and molecular modeling studies. Ghosh R; Dattagupta JK; Biswas S Biochem Biophys Res Commun; 2007 Nov; 362(4):965-70. PubMed ID: 17767923 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex. Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Obata S; Oguma K; Ohyama T Biochem Biophys Res Commun; 2002 Mar; 292(2):434-40. PubMed ID: 11906181 [TBL] [Abstract][Full Text] [Related]
10. Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications. Dineen SS; Bradshaw M; Johnson EA Curr Microbiol; 2003 May; 46(5):345-52. PubMed ID: 12732962 [TBL] [Abstract][Full Text] [Related]
11. Characterization of botulinum progenitor toxins by mass spectrometry. Hines HB; Lebeda F; Hale M; Brueggemann EE Appl Environ Microbiol; 2005 Aug; 71(8):4478-86. PubMed ID: 16085839 [TBL] [Abstract][Full Text] [Related]
12. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease. Dekleva ML; DasGupta BR Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520 [TBL] [Abstract][Full Text] [Related]
13. Identification of structural genes for Clostridium botulinum type C neurotoxin-converting phage particles. Hwang HJ; Lee JC; Yamamoto Y; Sarker MR; Tsuchiya T; Oguma K FEMS Microbiol Lett; 2007 May; 270(1):82-9. PubMed ID: 17302935 [TBL] [Abstract][Full Text] [Related]
14. Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination. Sagane Y; Kouguchi H; Watanabe T; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T Biochem Biophys Res Commun; 2001 Nov; 288(3):650-7. PubMed ID: 11676492 [TBL] [Abstract][Full Text] [Related]
15. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex. Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834 [TBL] [Abstract][Full Text] [Related]
16. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex. Raphael BH; Andreadis JD J Microbiol Methods; 2007 Dec; 71(3):343-6. PubMed ID: 17961766 [TBL] [Abstract][Full Text] [Related]
17. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design. Agarwal R; Binz T; Swaminathan S Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577 [TBL] [Abstract][Full Text] [Related]
18. Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene. Suzuki T; Nagano T; Niwa K; Uchino M; Tomizawa M; Sagane Y; Watanabe T Curr Microbiol; 2017 Jan; 74(1):49-54. PubMed ID: 27785552 [TBL] [Abstract][Full Text] [Related]
19. Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity. Rowe B; Schmidt JJ; Smith LA; Ahmed SA Anal Biochem; 2010 Jan; 396(2):188-93. PubMed ID: 19782037 [TBL] [Abstract][Full Text] [Related]
20. NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison. Bjorndahl TC; Andrew LC; Semenchenko V; Wishart DS Biochemistry; 2007 Nov; 46(45):12945-58. PubMed ID: 17944485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]